26508947 en pulmonary langerhans cell histiocytosis uncommon diffuse cystic lung disease adult rare case involve extrapulmonary organ lead endocrine abnormality central diabetes insipidus on 42-year-old man present polyphagia polydipsia well dry cough dyspnea exertion magnetic resonance imaging hypothalamic-pituitary system fail show posterior pituitary typical finding patient central diabetes insipidus condition confirmed water deprivation test patient also found type 2 diabetes mellitus compute tomographic scanning lung revealed multiple irregular shape cystic lesion small nodule bilateral sparing costophrenic angle lung biopsy video-assisted thoracoscopic surgery revealed pulmonary langerhans cell histiocytosis follow-up visit 1 year patient quit smoking clinical radiological improvement significant report uncommon case pulmonary langerhans cell histiocytosis simultaneous present diabetes insipidus diabetes mellitus 
27239592 en report case wolfram syndrome WS characterize diabetes mellitus diabetes insipidus progressive optic atrophy deafnessa 19-year-old female patient known case diabetes mellitus type I six year present progressive vision loss since four year early fundoscopic examination bilateral optic atrophy without diabetic retinopathy patient also diabetes insipidus neurosensory deaf neurogenic bladderws consider differential diagnosis patient diabetes mellitus present optic atrophy necessary perform hearing test well collecting 24-h urine output 
26913870 en physiological condition fluid electrolyte homoeostasis maintain kidney adjust urine volume composition according body need diabetes insipidus complex heterogeneous clinical syndrome affecting water balance characterize constant diuresis resulting large volume dilute urine respect similar name diabetes mellitus disease already known ancient egypt greece asia diabetes insipidus describe several thousand year late 1670s thomas willis noted difference taste urine polyuric subject compare healthy individual start differentiation diabetes mellitus rare entity diabetes insipidus 1794 johann peter frank describe polyuric patient excrete nonsaccharine urine introduce term diabetes insipidus hystorical milestone 1913 farini successful use posterior pituitary extract treat diabetes insipidus 1920s available evidence indicate diabetes insipidus disorder pituitary gland early 1928 de lange first observed patient diabetes insipidus respond posterior pituitary extract subsequent forssman waring 1945 establish kidney critical role form diabetes insipidus resistant treatment 1947 williams henry introduce term nephrogenic diabetes insipidus congenital syndrome characterize polyuria renal concentrate defect resistant vasopressin 1955 du vigneaud receive 1955 nobel prize chemistry first synthesis hormone vasopressin represent milestone treatment central diabetes insipidus 
21842608 en report herein 27-year-old male case inherit distal renal tubular acidosis complicated renal diabetes insipidus symptom aggravate occurrence diabetes mellitus 2 month birth diagnose inherit distal renal tubular acidosis thereafter supplementation potassium alkali start treat hypokalemia metabolic acidosis age 4 year calcification bilateral renal medulla detect compute tomography subsequent urinary volume gradual increased polyuria approximate 4 lday persist age 27 year become fond sugar-sweetened drink also often forget take medicine admitted hospital due polyuria 10 l day muscle weak gait disturbance laboratory test disclose worsen hypokalemia metabolic acidosis addition severe hyperglycemia seem likely occurrence diabetes mellitus cessation medication induce osmotic diuresis aggravate hypokalemia metabolic acidosis consequent severe dehydration hypokalemia-induced damage urinary concentration ability enhancement renin angiotensin system occur thereby possible worsen hypokalemia metabolic acidosis normalization hyperglycemia metabolic acidosis might exacerbate hypokalemia dehydration hypokalemia treat first following intensive treatment abnormality improve polyuria persist elevated plasma antidiuretic hormone 120 pgml deficit renal response antidiuretic hormone suggested polyuria attributable preexisting renal diabetes insipidus possible cause bilateral renal medulla calcification thiazide diuretic nonsteroidal anti-inflammatory drug effective treatment diabetes insipidus present case 
15526727 en patient diabetes mellitus present worsen polyuria polydipsia sensible cost-effective approach report unique coincidence type 2 diabetes mellitus diabetes insipidus on 46-year-old woman poor control type 2 diabetes complain polyuria daily output 5 l although urinalysis demonstrated significant glucosuria diabetes insipidus suspected owe low urine specific gravity 1008 low specific gravity persist water deprivation test ultimate diabetes insipidus confirmed urine specific gravity urine osmolality normalize following desmopressin administration case emphasize importance accurate interpret urine specific gravity patient polyuria diabetes mellitus detect diabetes insipidus 
26181158 en autoimmune polyglandular syndrome condition characterize combination two organ-specific disorder underestimation oftheir real frequency probable result physician inadequate knowledge clinical entity sometime atypical clinical presentation comprise wide spectrum autoimmune disorder autoimmune polyglandular syndrome divided four type among type-3 common one article report case young female initial diagnose diabetes mellitus several year late develop full-blown autoimmune polyglandular syndrome type 3 consist autoimmune thyroid disorder latent autoimmune diabetes adultsthe discuss case suggest select patient diabetes insipidus may coexist autoimmune endocrinopathies nonendocrine autoimmunopathies well patient idiopathic diabetes insipidus may secondary lymphocytic infiltration destruction hypothalamic supraoptic paraventricular nucleus andor supraoptic-hypophyseal tract 
5476203 en report rare case concurrent manifestation central diabetes insipidus CDI type 2 diabetes mellitus DM on 56 year-old man diagnose type 2 DM basis hyperglycemia polyuria polydipsia local clinic two month ago start oral hypoglycemic medication result symptomatic improvement upon admission university hospital patient initial fasting blood sugar level 140 mgdl show polydipsic polyuric condition 8 l urineday despite hyperglycemia control metformin diet symptom persist investigation include water deprivation test confirmed coexist CDI unknown origin patient symptom include intense thirst marked improve desmopressin nasal spray 10 gday possibility common origin CDI type 2 DM raise review relevant adult case literature 
18613120 en wolfram syndrome WS autosomal recessive neurodegenerative disorder characterize diabetes mellitus DM optic atrophy OA central diabetes insipidus CDI deaf d phenotype disease associate several mutation WFS1 gene nuclear gene localize chromosome 4 since discovery association WFS1 gene wolfram syndrome 150 mutation identify WS patient previous describe first case perinatal onset wolfram syndrome newborn carry segmental uniparental heterodysomy affecting short arm chromosome 4 responsible significant reduction wolframin expression review discuss pathophysiological mechanism believe responsible perinatal onset wolfram syndrome datum strong suggest role WFS1 gene foetal neonatal neurodevelopmentwe describe male patient 30 week gestation intrauterine growth restriction poly-hydramnios first day life patient show 19 weight loss associate polyuria hypernatremia presence persistent hypernatremia serum sodium 150 meql high plasma osmolarity 322 mosml low urine osmolarity 190 mosml uosmposm ratio 1 consistent CDI diagnosis CDI confirmed desmopressin test brain magnetic resonance imaging MRI 34 week age show lack posterior pituitary hyperintense signal addition bilateral asymmetrical optic nerve hypoplasia associate right orbital bone hypoplasia observed suggest diagnosis WF five year follow-up patient develop glucose intolerance diabetes mellitus end second year life primary non-autoimmune central hypothyroidism mild neurodevelopment retardation diagnosedthe analysis case light recent literature suggest possible role WFS1 gene development certain brain structure fetal period wolfram syndrome consider differential diagnosis rare case congenital central diabetes insipidus develop neonatal period 
20888099 en diabetes insipidus ancient disease consider rubric diabetes greek descriptive term polyuria unrecognized even sweet urine reported characteristic diabetes mellitus 17th century will another century diabetes insipidus identify insipid rather saccharine taste urine case polyuria increased recognition pathologic observation experimental study connected diabetes insipidus pituitary gland opening decade 20th century simultaneous posterior pituitary lobe extract show vasoconstrictive vasopressin antidiuretic antidiuretic hormone vasopressin purify synthesize assay become available show release response osmotic volume stimulus integrate hypothalamus vasopressin thereby essential maintain internal water balance antidiuretic property vasopressin treat rare case diabetes insipidus limited clinical utility vasoconstrictive effect resuscitate 1970s consequent increasing wide use vasopressin treatment compromise hemodynamic state addition discovery antidiuretic hormone receptor blocker lead increasing use manage hypo-osmolar state 
26401579 en adipsic diabetes insipidus ADI rare disorder consist central diabetes insipidus CDI deficient absent thirst response hyperosmolality patient ADI experience marked morbidity mortality diagnosis management patient quite challenging even expert hand review aim provide update overview difficult clinical scenariowe conduct pubmed search article related ADI search term adipsia adipsic thirst diabetes insipidus use identify relevant literatureadi describe approximate 100 patient rarity limited quality quantity literature case report case series expert opinion diagnosis focus confirmation CDI follow document subnormal complete absent thirst response hypertonic stimulus among describe patient ADI majority experience morbidity eg severe hypernatremia sleep apnea venous thromboembolism VTE obesity increased mortality risk management focus frequent reassessment daily prescribe water intake fixed antidiuretic therapy desmopressin comorbidity screeningthe complexity patient ADI provide difficult challenge clinician prompt recognition thirst disorder patient CDI lead appropriate regiment management strategy result safe outpatient care unique patient 
26051300 en central diabetes insipidus CDI complex heterogeneous clinical syndrome affecting hypothalamic-neurohypophyseal network water balance on recent national surveillance denmark show prevalence rate twenty-three CDI patient per 100000 inhabitant five year differential diagnosis several present condition polyuria polydipsia puzzling etiological diagnosis CDI remain challenge identification underlie cause clinical practice timely diagnosis initiate specific treatment order avoid central nervous system damage additional pituitary defect risk dissemination germ cell tumor advisable proper etiological diagnosis achieve via series step start careful clinical observation several sign endocrine symptom progress sophisticate imaging tool review summarize best practice approach diagnosis treatment patient CDI 
25211589 en diabetes mellitus wide known ancient polyuria glycosuria bud diabetes insipidus DI 200 year ago base glucose-free polyuria characterize subset patient late 19th century clinician identify posterior pituitary site pathology pharmacologist found multiple bioactivities early 20th century amelioration polyuria extract posterior pituitary inaugurate new era therapy advance hypothesis DI due hormone deficiency decade late subset patient polyuria unresponsive therapy recognize leading distinction central DI nephrogenic DI early example hormone-resistant condition recognition posterior pituitary 2 hormone follow du vigneauds nobel prize winning isolation sequencing chemical synthesis oxytocin vasopressin pure hormone accelerated development bioassays immunoassays confirmed hormone deficiency vasopressin-sensitive DI abundant level hormone patient nephrogenic disorder form disease acquire inborn defect recognize emerge concept receptor genetic analysis lead recognition patient mutation genes 1 arginine vasopressin AVP 2 AVP receptor 2 AVPR2 3 aquaporin 2 water channel AQP2 recount multiple skein clinical laboratory research intersect frequent century since first recognition DI 
26783152 en central diabetes insipidus CDI cardiac arrest well describe thus aim study occurrence outcome risk factor CDI survivor out-of-hospital cardiac arrest ohcawe retrospective analyzed post-ohca patient treat single center central diabetes insipidus retrospective define diagnostic criterium one-month cerebral performance category CPC score collected outcomesof 169 patient evaluate 36 patient 213 diagnose CDI CDI patient poor neurologic outcome either CPC 4 139 CPC 5 861 CDI strong associate mortality age odd ratio or 096 95 confidence interval CI 093-099 respiratory arrest or 662 95 CI 123-3544 asphyxia or 926 95 CI 217-3461 gray white matter ratio brain compute tomogram or 088 95 CI 081-095 associate development CDI onset CDI early p 001 maximum 24-hour urine output large p 03 patient worst outcomesall patient diagnose CDI poor neurologic outcome occurrence CDI associate mortality central diabetes insipidus patient death brain death early occurrence CDI maximum urine output 
24517985 en report incidence etiology treatment diabetes insipidus-like state complicate percutaneous transluminal renal stenting PTRS transplant renal artery stenosis trasdata 7 patient PTRS TRAS perform october 2008 march 2012 review retrospective parameter investigate included blood flow velocity blood pressure creatinine level interventionthe procedural success rate 100 three case develop diabetes insipidus-like state immediate postprocedural period urine output return normal within 2 week treatment median blood flow velocity significant reduce 451 msec 431-461 msec time TRAS diagnosis 133 msec 131-151 msec recent follow-up group diabetes insipidus-like state ratio median blood flow velocity stenting group diabetes insipidus-like state significant high group without diabetes insipidus-like state 339 vs 193diabetes insipidus-like state complicate PTRS TRAS uncommon event appear underreported medical literature on high ratio pre- poststenting median blood flow velocity may predictor postprocedural diabetes insipidus-like state probable cause may marked increase renal arterial flow early recognition condition essential avoid dehydration electrolyte imbalance 
26795631 en x-linked nephrogenic diabetes insipidus NDI OMIM304800 cause mutation arginine vasopressin AVP OMIM192340 receptor type 2 AVPR2 OMIM300538 gene on 20-month-old boy 8-year-old brother present polyuria polydipsia failure thrive boy demonstrated partial DDAVP 1-desamino-8-d AVP desmopressin response thus NDI diagnosis delay routine sequencing AVPR2 show potential splice site variant exome sequencing confirmed AVPR2 splice site variant reveal likely candidate patient diagnosis make proper treatment institute patient hemizygous two AVPR2 variant predict silico affect AVPR2 messenger RNA mrna splice on minigene assay revealed novel AVPR2 c276ag mutation create novel splice acceptor site leading 5 truncation AVPR2 exon 2 HEK293 human kidney cell patient treat high-dose DDAVP remarkable improvement symptom accelerated linear growth weight gainwe present unique case partial x-linked NDI due AVPR2 splice site mutation patient diabetes insipidus unknown etiology may harbor splice site mutation initial underestimate pathogenicity sequence analysis x-linked nephrogenic diabetes insipidus cause AVPR2 mutation disease severity vary depend functional effect mutation new demonstrate splice site mutation AVPR2 lead partial x-linked NDI two brother treatment high-dose DDAVP lead improvement polyuria polydipsia weight gain growth 
25587001 en diabetes insipidus rare serious endocrine disorder paediatric patient evaluate polyuria king khalid university hospital riyadh saudi arabia decade 2000-13 relevant clinical examination andor triad high serum osmolality hypernatremia low urine osmolality due increased urine output confirmed diagnosis water deprivation test require case non-classic presentation appropriate brain imaging perform whenever central diabetes insipidus CDI suspected twenty-eight patient 15 malis 536 13 female 464 aged 0-17 year mean 6 year included calculated period prevalence 7 10000 cohort 607 17 28 patient CDI 214 6 28 diagnose nephrogenic diabetes insipidus NDI 179 5 30 psychogenic polydipsia CDI due variable aetiology though CDI common NDI rare encounter community possible high consanguineous marriage 
26485413 en combined central diabetes insipidus cerebral salt wasting syndrome traumatic brain injury TBI rare characterize massive polyuria leading severe water electrolyte disturbance usual associate high mortality main result delay diagnosis improper managementwe retrospective review clinical presentation management outcome 11 patient develop combined central diabetes insipidus cerebral salt wasting syndrome traumatic brain injury define distinctive feature timely diagnosis proper managementthe typical clinical presentation massive polyuria 10000 ml24 hour 1000 mlhour refractory vasopressin alone responsive vasopressin plus cortisone acetate characteristic presentation included low central venous pressure high brain natriuretic peptide precursor level without cardiac dysfunction high 24-hour urine sodium excretion hypovolemia much high urine serum osmolarity normal serum sodium level urine specific gravity also present timely adequate infusion sodium chloride key treatment 11 patient 5 good prognosis 3 month late extended glasgow outcome scale score 6 1 extended glasgow outcome scale score 4 2 die hospital brain hernia 3 develop vegetative statefor combined diabetes insipidus cerebral salt wasting syndrome traumatic brain injury massive polyuria major typical presentation intensive monitor fluid sodium status key timely diagnosis achieve favorable outcome proper sodium chloride supplementation cortisone acetate vasopressin coadministration key 
25006753 en present two case transient central diabetes insipidus preterm neonate post-hemorrhagic hydrocephalus although association intraventricular hemorrhage diabetes insipidus describe preterm infant association diabetes insipidus hydrocephalus fact central diabetes insipidus can reversible reduction ventricular size either spontaneous resolution placement ventriculo-peritoneal shunt first describe neonate 
25902753 en molecular diagnosis useful diagnostic tool primary nephrogenic diabetes insipidus NDI inherit disease characterize renal inability concentrate urine AVPR2 AQP2 genes screen mutation cohort 25 patient clinical diagnosis NDI patient present dehydration polyuria-polydipsia failure thrive mean SD z-height -19 21 z-weight -24 17 severe hypernatremia mean SD na 150 10 meql increased plasma osmolality mean SD 311 18 mosmkg normal glomerular filtration rate genetic diagnosis revealed 24 male patient hemizygous 17 different putative disease-causing mutation AVPR2 gene one different family nine previous reported eight recurrent moreover found AVPR2 change 12 relative heterozygous carrier one female patient AVPR2 gene study turn negative found homozygous novel AQP2 pala86val alterationgenetic analysis presumable confirmed diagnosis nephrogenic diabetes insipidus every patient studied cohort emphasize detect high presence 50 heterozygous female clinical NDI symptom case 90 inherit nephrogenic diabetes insipidus NDI x-linked disease cause mutation AVPR2 gene rare occasion 10 cause mutation AQP2 gene new study report 10 novel mutation associate NDI detect high presence 50 heterozygous carrier clinical NDI symptom 
417219 en many complication reported cardiopulmonary bypass on common physiologic change early postoperative period cardiopulmonary bypass increased diuresis patient whose urine output increased postoperative diabetes insipidus develop although report rare present case 2 patient undergo on-pump coronary artery bypass grafting cardiopulmonary bypass diagnose diabetes insipidus postoperative 54-year-old man 3rd day 66-year-old man 4th day patient recover condition 6 hour intranasal therapy synthetic vasopressin antidiuretic hormone diagnosis diabetes insipidus consider patient produce excessive urine early cardiac surgery cardiopulmonary bypass use 
1509881 en neurological manifestation dengue fever occur 1 patient known due multisystem dysfunction secondary vascular leakage occurrence wide spread cerebral haemorrhage subdural hematoma leakage phase without profound thrombocytopenia occurrence cranial diabetes insipidus extreme rare reported publish literature early thus report first casea 24 year old previous healthy lady admitted third day fever thrombocytopenia critical phase start fifth day evidence pleural effusion moderate ascites thirty one hour critical phase develop headache alter level conscious limb rigidity respiratory depression without definite seizure non-contrast CT brain do tertiary care level revealed diffuse intracranial haemorrhage sub arachnoid haemorrhage right frontal parietal occipital lobe brainstem cerebral oedema acute subdural hematoma right temporo- parietal region platelet count 40000 time sign vascular leakage intubate ventilate supportive care late develop feature cranial diabetes insipidus respond intranasal desmopressin therapy spite measure sign brainstem herniation develop succumb ill day 8 dengue confirmed serologicallyexact pathophysiological mechanism diffuse cerebral haemorrhage without profound thrombocytopenia well understand increased aware high degree clinical suspicion need among clinician timely diagnosis extreme rare complication dengue fever postulate immunological mechanism may play role pathogenesis however comprehensive research study need understand pathophysiological mechanism leading complication 
27156762 en neurohypophyseal diabetes insipidus characterize polyuria polydipsia owe partial complete deficiency antidiuretic hormone arginine vasopressin AVP although patient non-hereditary cause underlie disorder genetic form long recognize studied vivo vitro affected families disease transmit autosomal dominant manner whereas autosomal recessive form much less frequent phenotype cause mutation vasopressin-neurophysin ii AVP gene transfected cell express dominant mutation mutate hormone precursor retain endoplasmic reticulum form fibrillar aggregate autopsy study human murine knock-in model suggest dominant phenotype result toxicity vasopressinergic neuron mechanism leading cell death remain unclear recessive transmission result AVP reduce biologic activity deletion locus genetic neurohypophyseal diabetes insipidus occur context diabetes mellitus optic atrophy deaf term DIDMOAD wolfram syndrome genetically phenotypically heterogeneous autosomal recessive disorder cause mutation wolframin WFS 1 gene 
23884272 en gestational diabetes insipidus rare transient complication pregnancy typical characterize polyuria polydipsia may lead mild electrolyte abnormality severe sequelae gestational diabetes insipidus uncommonwe present case 25-year-old woman 23 week gestation dichorionic-diamniotic twin pregnancy develop severe symptomatic gestational diabetes insipidus complicated rhabdomyolysis death fetusesmaternal rhabdomyolysis cause gestational diabetes insipidus extreme rare early recognition treatment gestational diabetes insipidus necessary prevent maternal fetal morbidity mortality 
27156767 en diabetes insipidus inability concentrate urine resulting polyuria polydipsia different manifestation management consideration infant child compare adult central diabetes insipidus secondary lack vasopressin production common child nephrogenic diabetes insipidus inability respond appropriate vasopressin goal treatment form diabetes insipidus decrease urine output thirst allow appropriate fluid balance normonatremia ensure acceptable quality life patient infant obligate need consume calorie liquid need readjustment medication dose growing child present unique challenge diabetes insipidus management pediatric population treatment modality typical include vasopressin thiazide diuretic special consideration must given manage diabetes insipidus adipsic patient post-surgical patient undergo chemotherapy receive medication alter free water clearance 
25951703 en diabetes insipidus uncommon disorder water-electrolyte balance characterize excretion abnormal large volume dilute urine polyuria increased fluid intake polydipsia disease may result insufficient production vasopressin increased degradation impair response kidney vasopressin may secondary excessive water intake patient severe uncompensated symptom may develop marked dehydration neurologic symptom encephalopathy therefore diabetes insipidus life-threatening condition proper diagnose manage patient diabetes insipidus require treatment desmopressin drug increasing sensitivity distal nephron vasopressin treatment may confusing disorder variable pathophysiology side-effects pharmacotherapy review summarize current knowledge different aspect pathophysiology classification clinical presentation diagnosis management diabetes insipidus reader also provide practical recommendation dealing patient suffering disease 
4552918 en ifosfamide-induced fanconi syndrome rare complication typical occur young patient due cumulative dose ifosfamide 40-60 gm2 reduction kidney mass concurrent cisplatin treatment usual characterize severe fatal progression accompany type ii proximal renal tubular dysfunction evidence glycosuria proteinuria electrolyte loss metabolic acidosis diabetes insipidus also rare complication ifosfamide-induced renal disease herein describe case involve 61-year-old man develop ifosfamide-induced fanconi syndrome accompany diabetes insipidus day first round chemotherapy known risk factor addition brief review mechanism possible therapeutic option condition base case literature patient receive ifosfamide must close monitor renal impairment avoid rare fatal complication 
24132004 en multiple sclerosis ms complex neurodegenerative disease present diversity clinical symptom include palsy cognitive impairment present 59-year-old woman history secondary progressive ms since 1987 refer department recent onset confusion polydipsia initial lab test show mild elevated serum sodium level low urine osmolality water deprivation diuresis low urine osmolality persist serum sodium level rose 150 mmoll oral desmopressin result normalisation serum sodium well urine osmolarity confirming diagnosis central diabetes insipidus drug-induced diabetes can exclude pituitary magnetic resonance imaging MRI perform on demyelinating lesion detect hypothalamus patient start oral desmopressin treatment 02 mgday fluid intake serum sodium level since remain normal summary report rare case patient present diabetes insipidus due progressive ms diabetes insipidus consider ms patient develop new onset polydipsia 
24631797 en previous study central diabetes insipidus suggested thiazides acute exert paradoxical antidiuresis either indirect activate volume-homeostatic reflex decrease distal fluid-delivery direct stimulating distal water-reabsorption study investigate whether direct indirect action bendroflumethiazide BFTZ simultaneous cooperate also whether renal nerve involved induce long-term antidiuresis nephrogenic diabetes insipidus NDI BFTZ vehicle gavaged bilateral renal denervated innervate rat lithium-induced NDI 10 day constitute four group one day D0 one five ten day starting administration BFTZ vehicle rat place metabolic cage collect urine 6 hour bftz-treatment renal innervate denervated rat cause equivalent reduction urine-flow creatinine clearance lithium clearance free-water clearance rise urine-osmolality fractional proximal reabsorption fractional distal reabsorption day compare D0 well relevant vehicle-received group therefore chronic antidiuretic response BFTZ conscious NDI rat exert concomitant cooperation direct distal effect stimulating water-reabsorption indirect effect reduce distal fluid-delivery activate volume-homeostatic mechanism appear independent renal nerve 
26208472 en familial neurohypophyseal diabetes insipidus FNDI rare autosomal dominant inherit disorder characterize severe polydipsia polyuria general present early childhood present study aim analyze AVP gene turkish family fndifour patient neurohypophyseal diabetes insipidus ten healthy member family studied diabetes insipidus diagnose water deprivation test affected family member mutation analysis perform sequencing whole code region AVP-NPII gene use DNA isolated peripheral blood samplesurine osmolality low 300 mosmkg water deprivation test increase 50 urine osmolality recovery symptom observed administration desmopressin patient plasma copeptin level lower expected according plasma osmolality pituitary MRI revealed partial empty sella bright spot index patient normal neurohypophysis affected subject genetic screening revealed novel heterozygous mutation designate c-3ac patientsc-3ac mutation 5UTR AVP gene family might lead truncation signal peptide aggregation AVP cytoplasm instead target endoplasmic reticulum thereby can disrupt AVP secretion without cause neuronal cytotoxicity might explain presence bright spot predict effect mutation investigate vitro molecular study 
19703807 en study case 2 1012-year-old boy growth failure delay bone maturationwe review history revealed polyuria polydipsia lack weight gain frequent vomiting since age 5 month physical examination height 86 cm -193 standard deviation SD weight 105 kg -267 SD motor mental retardation maternal great-grandfather also polyuria polydipsia diabetes mellitus suggest x-linked nephrogenic diabetes insipidus underlie cause patient undergo water deprivation-desmopressin test code region AVPR2 gene amplify polymerase chain reaction submit direct sequence analysisthe water deprivation test confirmed diagnosis diabetes insipidus administration desmopressin diminish water secretion direct sequencing AVPR2 gene revealed novel deletion adenine position 222 222dela exon 2 mutation predict lead frameshift beginning amino acid 75 premature stop codon position 115 FS75115X height weight well motor skill improve initiation therapy hydrochlorothiazide amiloridegrowth delay associate diabetes insipidus x-linked nephrogenic diabetes insipidus boy cause novel mutation AVPR2 gene predict truncate receptor protein 
25301491 en wolfram syndrome WS also known DIDMOAD diabetes insipidus diabetes mellitus optic atrophy deaf rare autosomal recessive syndrome 1770000 united kingdom characterise juvenile onset diabetes mellitus optic nerve atrophy diabetes insipidus sensorineural deaf renal tract neurological abnormality primary gonadal atrophy WS cause main biallelic mutation WFS1 gene encode wolframin wide tissue distribution wolframin many mutation wolframin gene resulting wolfram syndrome may contribute different phenotype unusual combination clinical feature describe female patient wolfram syndrome diagnose age 25 previous false diagnosis type 1 diabetes mellitus misdiagnose diabetic complication patient found compound heterozygote two novel mutation exon 8 WFS1 gene 2-bp deletion at nt 1539 leading frameshift y513fs single-base substitution 1174C t resulting stop codon Q392X on detailed analysis patient medical history review literature suggest many case wolfram syndrome may remain undiagnosed due misdiagnosis type 1 diabetes mellitus incorrect interpretation clinical symptom neurodegenerative abnormality especial early stage 
20374732 en nephrogenic diabetes insipidus NDI inherit acquire characterize inability concentrate urine despite normal elevated plasma concentration antidiuretic hormone arginine vasopressin AVP polyuria hyposthenuria polydipsia cardinal clinical manifestation disease nephrogenic failure concentrate urine maximal may due defect vasopressin-induced water permeability distal tubule collecting duct insufficient buildup corticopapillary interstitial osmotic gradient combination two factor thus broad definition term NDI embrace antidiuretic hormone-resistant urinary-concentrating defect include medullary disease low interstitial osmolality renal failure osmotic diuresis 90 patient congenital NDI malis x-linked recessive NDI OMIM 3048001 mutation AVP receptor 2 AVPR2 gene code vasopressin V2 receptor gene locate chromosome region xq28 10 families studied congenital NDI autosomal recessive autosomal dominant mode inheritance OMIM 222000 1258001 mutation identify aquaporin-2 gene AQP2 OMIM 1077771 locate chromosome region 12q13 code vasopressin-sensitive water channel NDI clinical distinguishable neurohypophyseal diabetes insipidus OMIM 1257001 also refer central neurogenic diabetes insipidus lack response exogenous AVP plasma level AVP rise normal increase plasma osmolality hereditary neurohypophyseal diabetes insipidus secondary mutation gene encode AVP OMIM 1923401 neurohypophyseal diabetes insipidus also component autosomal recessive wolfram syndrome 1 DIDMOAD syndrome diabetes insipidus diabetes mellitus optic atrophy deaf OMIM 2223001 autosomal recessive disorder inherit disorder complex polyuro-polydipsic syndrome loss water sodium chloride calcium magnesium potassium include bartter syndrome OMIM 6016781 cystinosis OMIM 2198001 long-term lithium administration main cause acquire NDI use gene symbol approved Hugo gene nomenclature committee httpwwwgeneuclacuknomenclature provide OMIM entry numbers OMIM online mendelian inheritance man1 mckusick-nathans institute genetic medicine johns hopkins university baltimore MD national center biotechnology information national library medicine bethesda MD 2000 world wide web URL httpwwwncbinlmnihgovomim 
24588923 en change water metabolism regulation vasopressin AVP antidiuretic hormone ADH common complication pituitary surgery scarcity study compare different treatment monitor strategy disorder lack prior clinical guideline make difficult provide recommendation following methodology base grade evidence study review pathophysiology diabetes insipidus inappropriate ADH secretion pituitary surgery intended serve guide diagnosis differential diagnosis treatment monitor 
22433947 en central diabetes insipidus CDI end result number condition affect hypothalamic-neurohypophyseal system known cause include germinomacraniopharyngioma langerhans cell histiocytosis LCH local inflammatory autoimmune vascular disease trauma resulting surgery accident sarcoidosis metastasis midline cerebral cranial malformation rare case underlie cause genetic defect vasopressin synthesis inherit autosomal dominant autosomal recessive x-linked recessive trait diagnosis underlie condition challenging raise several concern patient parent require long-term follow-up proper etiological diagnosis achieve via series step start clinical observation progress sophisticate tool specific MRI identification pituitary hyperintensity posterior part sella consider clear marker neurohypophyseal functional integrity together careful analysis pituitary stalk shape size provide striking finding contribute diagnosis understanding form idiopathic CDI MRI stir short-inversion-time inversion recovery sequencing promising technology early identification lch-dependent CDI 
27780577 en nephrogenic diabetes insipidus condition characterize polyuria dilute urine due inability principal cell renal collecting duct respond antidiuretic hormone concentrate urine nephrogenic diabetes insipidus drug induce several chemotherapeutic agent reported cause bendamustine traditional chemotherapeutic agent studied treatment relapse systemic al amyloidosis report case 59-year-old man al amyloidosis develop partial nephrogenic diabetes insipidus receive bendamustine treatment al amyloidosis nephrogenic diabetes insipidus respond well sodium restriction hydrochlorothiazide desmopressin treatment allow patient receive subsequent bendamustine cycle without polyuria nephrogenic diabetes insipidus resolved short completion bendamustine therapy 
21301966 en adipsic diabetes insipidus ADI characterise impair thirst defective AVP secretion assess thirst response grade osmotic stimulation use visual analog scale VAS patient history ADI following surgery craniopharyngioma patient thought regain thirst response want confirm case objective relax strict fluid balance regimen three patient adipisa presence hypernatremia following surgery craniopharyngioma describe median age surgery 13 year range 11-15 year patient previous demonstrated desire drink despite serum osmolality excess 300 mosmolkg fluid balance maintain postoperative regimen involve fixed daily fluid intake DDAVP dose together daily weight regular assessment capillary sodium concentration patient thought regain thirst sensation assess hypertonic saline infusion HSI thirst measured use VAS patient undergo HSI test 4 6 9 month post surgery abnormal low AVP production raise plasma osmolalities visual analogue scale confirmed partial complete thirst recovery intensive regimen use maintain stable serum sodium concentration relaxed without patient subsequent develop significant hyperosmolar state show objective recovery thirst perception patient adipsia within 9 month surgery despite persistence cranial diabetes insipidus observation indicate osmoreceptors regulate thirst efferent pathway demonstrate plasticity regulate AVP production HSI thirst VAS objective way assess patient known ADI thought recover thirst perception 
17536072 en previous study suggested patient suffering wolfram syndrome DIDMOAD diabetes insipidus diabetes mellitus optic atrophy deaf might relative preserve diabetic retinopathy nephropathy however datum conclusive either observation anecdotic match control type 1 diabetic populationsa group 26 french diabetic patient DIDMOAD compare population 52 patient common type 1 diabetes match age diabetes diagnosis 862 - 184 vs 827 - 130 year p NS diabetes duration 1288 - 158 vs 1287 - 113 year p NS study quality glycemic control incidence microvascular complicationsglycemic control significant better DIDMOAD group type 1 diabetic group A1C 772 - 021 vs 899 - 025 respective p 0002 significant lower daily insulin requirement 071 - 007 vs 088 - 004 UI x kg-1 x day-1 respective p 00325 prevalence microvascular complication DIDMOAD group half observed type 1 diabetic group difference significantdiabetes DIDMOAD patient easy control despite presence handicap better glycemic control can explain trend decrease microvascular diabetes complication observed previous study 
26466837 en limited datum regard effect alter serum osmolality cardiac electrical activity aim present study evaluate electrocardiographic ECG effect diabetes insipidus DI related hyperosmolality population young patient DI without known cardiovascular disease risk factorstwelve-lead ecgs 44 consecutive untreated young male patient age 218 29 year refer endocrinology clinic diagnose DI base water deprivation test retrospective evaluate on total 30 age-matched 219 24 year healthy malis select control group ecgs control obtain comparison ecgs DI patient ECG parameter measured comparedduration QRS complex significant short patient DI compare control 852 120 vs 940 106 ms p 0001 p wave dispersion PWD patient DI significant high compare control 319 99 vs 265 106 ms p 003 significant correlate serum osmolality serum sodium level r - 036 p 002 r - 035 p 002 respectivelydi patient without cardiovascular disease risk factor display significant short QRS duration increased p wave dispersion compare control 
2505538 en temozolomide TMZ alkylating agent primary use treat tumors central nervous system describe 2 patient apparent tmz-induced central diabetes insipidus use institution research patient database registry identify 3 additional potential case tmz-induced diabetes insipidus among group 1545 patient treat TMZA 53-year-old male oligoastrocytoma 38-year-old male oligodendroglioma develop symptom polydipsia polyuria approximate 2 month initiation TMZ laboratory analysis demonstrated hypernatremia urinary concentrate defect consistent presence diabetes insipidus patient successful treat desmopressin acetate desmopressin acetate withdrawn discontinuation TMZ diabetes insipidus recur magnetic resonance imaging pituitary hypothalamus unremarkable apart absence posterior pituitary bright spot case anterior pituitary function test normal case use research patient database registry database identify 2 index case 3 additional potential case diabetes insipidus estimate prevalence 03 5 case diabetes insipidus per 1545 patient prescribe tmzcentral diabetes insipidus rare reversible side effect treatment TMZ 
22520736 en central diabetes insipidus case see general practice acquire rare case hereditary autosomal dominant recessive neurohypophyseal diabetes insipidus provide cellular understanding mechanism responsible pre-hormone folding maturation release autosomal dominant central diabetes insipidus secondary toxic accumulation vasopressin mutant fibrillar aggregate endoplasmic reticulum hypothalamic magnocellular neuron produce vasopressin well trpv1-- trpv4-- mouse shed new light perception tonicity stretch receptor trpvs express central peripheral neuron genomic information provide sequencing AVP gene key routine care patient genetic disease reduce health cost provide psychological benefit patient families addition simple inexpensive blood urine measurement together clinical characteristic brain magnetic resonance imaging MRI can distinguish central nephrogenic polydipsic case 
25449762 en congenital nephrogenic diabetes insipidus rare hereditary disease main x-linked inheritance 90 case also autosomal recessive dominant form congenital nephrogenic diabetes insipidus characterize resistance renal collecting duct action arginine vasopressin hormone responsible inability kidney concentrate urine x-linked form due inactivate mutation vasopressin 2 receptor gene leading loss function mutate receptor affected malis often symptomatic neonatal period lack weight gain dehydration hypernatremia mild phenotype may also occur female carry mutation may asymptomatic sometime severe polyuria found due random x chromosome inactivation autosomal recessive dominant form occur gender link mutation aquaporin-2 gene treatment remain difficult especial infant base low osmotic diet increased water intake use thiazides indomethacin main goal avoid hypernatremic episode maintain good hydration state potential specific treatment case x-linked congenital nephrogenic diabetes insipidus pharmacological chaperone non-peptide vasopressin-2 receptor antagonist available future converse nephrogenic syndrome inappropriate antidiuresis NSIAD link constitutive activation v2-receptor due activate mutation clinical biological feature inappropriate antidiuresis low undetectable plasma arginine vasopressin hormone level 
26331225 en diabetes insipidus disease large volume dilute urine polyuria excrete due vasopressin AVP deficiency central diabetes insipidus CDI AVP resistance nephrogenic diabetes insipidus majority patient occurrence CDI related destruction degeneration neuron hypothalamic supraoptic paraventricular nucleus common well recognize cause include local inflammatory autoimmune disease vascular disorder langerhans cell histiocytosis LCH sarcoidosis tumors germinomacraniopharyngioma metastasis traumatic brain injury intracranial surgery midline cerebral cranial malformation opportunity describe unusual case female patient develop autoimmune CDI following ureaplasma urealyticum infection review literature uncommon feature moreover also discuss potential mechanism ureaplasma urealyticum might favor development autoimmune CDI 
26928867 en describe 2-year-old female suprasellar primitive neuroectodermal tumor central diabetes insipidus DI develop polyuria natriuresis subsequent hyponatremia 36 hr cisplatin administration marked urinary loss sodium combination negative sodium balance lead diagnosis cisplatin-induced renal salt wasting syndrome RSWS subsequent clinical management challenging four week late discharge ICU without neurological sequela combination cisplatin-induced RSWS DI confusing need careful clinical assessment inaccurate diagnosis management result increased neurological injury 
26707038 en gestational diabetes insipidus rare complication however undiagnosed untreated may lead serious complication mother fetus study case 34-year-old female patient diabetes insipidus associate pregnancy reported discuss process diagnosis treatment particular emphasis monitor water-electrolyte imbalance labor 
25832854 en gestational diabetes insipidus GDI rare self-limited complication pregnancy related excess placental vasopressinase enzyme activity metabolized liver GDI common pregnancy complicated condition associate liver dysfunction present case 41-year-old woman 38 week gestation present pre-eclampsia severe feature include impair liver function renal insufficiency following cesarean section diagnose GDI complicated cerebral vasoconstriction demonstrated magnetic resonance angiography case raise possibility cerebral vasoconstriction may related cause GDI on high index suspicion GDI maintain patient present typical sign symptom especial setting pregnancy complication associate liver dysfunction 
25371144 en present symptom complication proposition management protocol child diagnose adipsic diabetes insipidus adiclinical biochemical analysis six pediatric patient diagnose adi four boy aged 5 13 16 17 two girl aged 25 10 etiology adi germinoma n 2 extensive surgery due optic glioma n 1 astrocytoma n 1 congenital brain malformation n 1 complication secondary bacterial meningitis n 1 two patient severe impair vision two hemiparesisin patient loss thirst reflex observed serum electrolyte patient show sodium concentration 159 1766 mmoll plasma osmolality 297 mosmolkg polyuria absent three severe dehydrate patient admission two patient DDAVP 1-desamino-8-d-arginine vasopressin desmopressin therapy withdrawn base lack polyuria deep venous thrombosis developedlack polydipsia polyuria key symptom diabetes insipidus DI may delay diagnosis adi may lead severe complication chronic hyperosmolar status fluid intake patient diagnose adi need supervise daily base calculated constant volume oral fluid daily measurement fluid balance body weight sodium level especial patient whose vision compromise physical unable take care 
26077742 en healthy kidney maintain fluid electrolyte homoeostasis adjust urine volume composition according physiological need final urine composition determined last tubular segment collecting duct water permeability collecting duct regulate arginine vasopressin AVP secretion AVP neurohypophysis regulate complex signalling network involve osmosensors barosensors volume sensor AVP facilitate aquaporin aqp-mediated water reabsorption via activation vasopressin V2 receptor AVPR2 collecting duct thus enable concentration urine nephrogenic diabetes insipidus NDI inability kidney respond AVP result functional AQP deficiency consequent affected patient constant diuresis resulting large volume dilute urine primary form NDI result mutation genes encode key protein AVPR2 AQP2 whereas secondary form associate biochemical abnormality obstructive uropathy use certain medication particular lithium treatment disease informed identification underlie cause review clinical aspect diagnosis NDI various aetiologies current treatment option potential future development 
24630998 en on case present 10-year old boy hypothalamic-pituitary axis disorder initial present diabetes insipidus progress panhypopituitarism on hidden hypothalamic lesion suspected case follow new lesion found pituitary stem three year late although tumor marker negative increase size biopsy perform histopathology reported lymphocytic hypophysitis increase tumor marker follow-up thus second biopsy perform diagnosis germinoma lymphocytic hypophysitis uncommon diagnosis child case reported case late diagnose germinoma believe case highlight importance follow-up child central diabetes insipidus normal MRI well taking diagnosis lymphocytic hypophysitislymphocytic infundibular neurohypophysitis definitive rare diagnosis age can mask germinoma record case 
27118135 en aim study review different animal model central diabetes insipidus neurobiological syndrome characterize excretion copious amount dilute urine polyuria consequent water intake polydipsia rise serum sodium concentration hypernatremia rodent central diabetes insipidus cause genetic disorder brattleboro rat also various traumaticsurgical intervention include neurohypophysectomy pituitary stalk compression hypophysectomy median eminence lesion regardless etiology central diabetes insipidus affect neuroendocrine system secrete arginine vasopressin neurohormone responsible antidiuretic function act trough renal system however central diabetes insipidus model also show disorder neurobiological system specific secretion oxytocin neurohormone involved body sodium excretion although hydromineral behaviors show different central diabetes insipidus model usual consider similar present review highlight relevant difference respect behaviors function individual neurobiological system affected increased understanding relationship neuroendocrine system involved associate hydromineral behaviors may allow appropriate action take correct behavioral neuroendocrine deficit 
21727914 en past two decade genetic molecular basis familial form diabetes insipidus elucidate diabetes insipidus clinical syndrome characterize excretion abnormal large volume dilute urine polyuria increased fluid intake polydipsia common type diabetes insipidus cause lack antidiuretic hormone arginine vasopressin vasopressin produce hypothalamus secrete neurohypophysis type diabetes insipidus refer neurohypophyseal diabetes insipidus syndrome also result resistance antidiuretic effect vasopressin kidney either level vasopressin 2 receptor aquaporin 2 water channel mediate re-absorption water urine refer renal nephrogenic diabetes insipidus differentiation two type diabetes insipidus primary polydipsia difficult owe existence partial well complete form vasopressin deficiency resistance seven different familial form diabetes insipidus known exist clinical presentation genetic basis cellular mechanism responsible vary considerable information lead improve method differential diagnosis can provide basis new form therapy 
26024973 en central diabetes insipidus CDI characterize polyuria polydipsia due deficiency vasopressin current treatment goal CDI improvement quality life QOL desmopressin DDAVP without develop hyponatremia however reliable measure QOL CDI patient evaluate original questionnaire QOL consist 12 question focus polyuria polydipsia DDAVP treatment CDI patient undergo switch nasal spray oral disintegrate tablet DDAVP twenty-five CDI patient nasal DDAVP treatment six new develop CDI 18 healthy individual without known polyuricpolydipsic disorder control subject enrol QOL score determined questionnaire enrollment 3 month start oral DDAVP treatment examine wilcoxon signed-rank test eleven question detect improvement QOL sum QOL score eleven question increased 292 56 nasal 368 45 oral DDAVP p 0001 clinical relevant change serum level na eliminate two question DDAVP treatment sum QOL score 153 65 untreated CDI patient 244 52 nasal treatment 289 49 oral DDAVP 295 36 healthy control difference among group significant p 005 steel-dwass test except patient treat oral DDAVP healthy control questionnaire use accurate assess QOL CDI patient 
26217664 en congenital nephrogenic diabetes insipidus NDI conformation disease resulting protein misfolding ninety percent mutation result inactivate mutation arginine vasopressin receptor 2 AVPR2 gene transmit x-linked fashion blocking response vasopressin resulting inability concentrate urine clinical feature include polyuria polydispsia dehydration hypernatremia general severe affected malis present variable female due skew inactivation x chromosome describe case 40-year-old woman history type 2 diabetes mellitus hyperlipidemia obesity present debilitate polyuria since age 5 clear diagnosis interesting son diagnose NDI genetic testing revealed heterozygous val88met mutation AVPR2 gene son hemizygous patient since successful treat diuretic low solute diet highlight although x-linked NDI patient much malis consider symptomatic female prevent delay diagnosis conformational disease NDI present subject research use pharmacological chaperone restore proper receptor membrane localization function 
8494347 en P2Y12 receptor P2Y12-R signaling mediate gi ultimate reduce cellular camp level camp central modulator arginine vasopressin avp-induced water transport renal collecting duct CD hypothesize express CD P2Y12-R may play role renal handling water health nephrogenic diabetes insipidus found P2Y12-R mrna expression rat kidney immunolocalized protein aquaporin-2 AQP2 CD principal cell administration clopidogrel bisulfate irreversible inhibitor P2Y12-R significant increased urine concentration AQP2 protein kidney sprague-dawley rat notable clopidogrel alter urine concentration brattleboro rat lack AVP clopidogrel administration also significant ameliorate lithium-induced polyuria improve urine concentrate ability AQP2 protein abundance reversed lithium-induced increase free-water excretion without decreasing blood kidney tissue lithium level clopidogrel administration also augment lithium-induced increase urinary AVP excretion suppress lithium-induced increase urinary nitratesnitrites nitric oxide production 8-isoprostane oxidative stress furthermore selective blockade P2Y12-R reversible antagonist PSB-0739 primary culture rat inner medullary CD cell potentiated expression AQP2 AQP3 mrna camp production induce ddavp desmopressin conclusion pharmacologic blockade renal P2Y12-R increase urinary concentrate ability augment effect AVP kidney ameliorate lithium-induced NDI potentiating action AVP CD strategy may offer novel effective therapy lithium-induced NDI 
25079469 en adipsic diabetes insipidus ADI rare disorder occur transcranial surgery craniopharyngeoma suprasellar pituitary adenoma anterior communicate artery aneurysm also head injury toluene exposure developmental disorder often associate significant hypothalamic dysfunction complication like obesity sleep apnea thermoregulatory disorder seizure venous thromboembolism VTE morbidity mortality datum reported single case report one large series suggest increased risk VTE patient ADI report mini-series four patient ADI VTE post-surgery immobilization obesity infection prolong hospitalization hemoconcentration change coagulation might induce inadequate hormone treatment postoperative period high dose glucocorticoids sex steroid DDAVP replacement may contribute pathogenesis VTE thromboprophylactic treatment pituitary surgery episode hypernatremia therefore warrant 
23587596 en congenital nephrogenic diabetes insipidus rare hereditary nature characterize inability kidney concentrate urine secondary manifold resistance action vasopressin x-linked form transmission 90 express boy neonatal period general polyuria polydipsia symptomatology transmissive girl variable sometime quite marked form secondary mutation gene encode vasopressin V2 receptor locate position xq28 responsible loss function receptor mutation may cause partial phenotype less severe form autosomal recessive dominant rare 10 treatment symptomatic sometime difficult infant aim avoid episode dehydration base conventional diet hypo-osmotic administration hydrochlorothiazide indomethacin report case child congenital nephrogenic diabetes insipidus hospitalize childrens hospital rabat throughout case review pathophysiology clinical biological characteristic disease include importance contribution clinical biochemistry laboratory diagnosis monitor disease 
23314181 en determine occurrence rate central diabetes insipidus pediatric patient severe traumatic brain injury describe clinical injury biochemical imaging intervention variable associate mortalityretrospective chart imaging reviewchildrens hospital level 1 trauma centerseverely injured injury severity score 12 pediatric trauma patient 1 month 18 yr severe traumatic brain injury presedation glasgow coma scale 8 head maximum abbreviate injury scale 4 develop acute central diabetes insipidus january 2000 december 2011of 818 severe injured trauma patient 180 severe traumatic brain injury overall mortality rate 272 thirty-two severe traumatic brain injury patient develop acute central diabetes insipidus respond desamino-8-d-arginine vasopressin andor vasopressin infusion provide occurrence rate 18 time central diabetes insipidus diagnosis median urine output serum sodium 68 mlkghr interquartile range 5-11 154 mmoll interquartile range 149-159 respective mortality rate central diabetes insipidus patient 875 714 declared brain dead central diabetes insipidus diagnosis early central diabetes insipidus onset within first 2 day severe traumatic brain injury strong associate mortality p 0001 lower presedation glasgow coma scale p 003 lower motor glasgow coma scale p 001 occurrence fixed pupil p 004 prolong partial thromboplastin time p 004 cerebral edema initial compute tomography obtain first 24 hrs injury imaging finding associate death p 0002 survivor central diabetes insipidus likely intracranial pressure monitor p 003 thiopental administer induce coma p 004 receive decompressive craniectomy elevated intracranial pressure p 004the incidence central diabetes insipidus pediatric patient severe traumatic brain injury 18 mortality associate early central diabetes insipidus onset cerebral edema head compute tomography central diabetes insipidus nonsurvivors less likely receive intracranial pressure monitor thiopental coma decompressive craniectomy 
22644838 en aim study identify mutation three different genes arginine-vasopressin-neurophysin ii AVP-NPII gene arginine-vasopressin receptor 2 AVPR2 gene vasopressin-sensitive water channel aquaporin-2 AQP2 gene turkish patient affected central diabetes insipidus nephrogenic diabetes insipidus study included 15 patient unrelated families prospective clinical datum collected patient include patient undergo water deprivation-desmopressin test code region AVPR2 AQP2 AVP-NPII genes amplify polymerase chain reaction submit direct sequence analysis 15 patient diabetes insipidus refer gulhane military medical academy department endocrinology metabolism eight patient AVPR2 mutation five patient AQP2 mutation two patient AVP-NPII mutation patient AVPR2 mutation one compound heterozygous AVPR2 gene seven mutation novel comparison clinical outcome mutation may facilitate understanding function AVP-NPII AQP2 AVPR2 genes future study 
26201512 en present case undiagnosed nephrogenic diabetes insipidus cause acute urinary retention 21-year-old male soldier soldier live close quarter regiment lifestyle may allow frequent voiding therefore undiagnosed nephrogenic diabetes insipidus may result acute urinary retention 
25330715 en primary mitochondrial disease refer group heterogeneous complex genetic disorder affecting 15000 people true prevalence anticipate even high complexity achieve diagnosis many patient present multisystemic complaint range infancy adulthood diabetes prominent feature several disorder might overlook endocrinologist review mitochondrial disorder describe phenotypic pathogenetic difference mitochondrial diabetes mellitus mdm common form diabetes mellitus 
24519262 en pulmonary langerhans cell histiocytosis PLCH occur predominant young adult smoker diabetes insipidus occur 15 patient PLCH information PLCH pregnancy sparse especial associate diabetes insipidus report three patient condition describe disease history pregnancy outcome 
20500966 en review etiology diagnosis management diabetes insipidus pregnancya search literature perform pubmed use key word searching citation snowball identify article publish english january 1 1980 december 31 2008 subject diabetes insipidus pregnancy article identify thorough review result conduct result conclusion compile summarizedwe review 50 study select use following key word diabetes insipidus pregnancy arginine vasopressin vasopressinasegestational diabetes insipidus underdiagnosed polyuria often consider normal pregnancy clinician caring pregnant woman consider screening gestational diabetes insipidus can associate serious underlie pathology 
27807328 en 2010201483P005P005P00537446607231437 d192291p0051p005 
7739683 en normalization cortisol concentration multikinase inhibitor reported three patient medullary thyroid cancer-related cushings syndrome aortic dissection reported three patient cushings syndrome diabetes insipidus without intrasellar metastasis intestinal intussusception paraneoplastic dysautonomia reported medullary thyroid canceran adult male metastatic medullary thyroid cancer present hyperglycemia hypernatremia hypokalemia hypertension acne-like rash diabetes insipidus urine volume 8 ld osmolality 190 mosmkg serum cortisol adrenocorticoitropic hormone dehydroepiandrostenedione sulfate urinary free cortisol elevated 8 20 44 340 fold respective pituitary imaging normal compute tomography scan revealed jejunal intussusception incidental abdominal aortic dissection sorafenib treatment associate cushings syndrome remission elevated progesterone 10 fold normalization dehydroepiandrostenedione sulfate persistent elevated cortisol concentration newly-developed proximal lower limb weak decrease salivation associate elevated ganglionic neuronal acetylcholine receptor alpha-3 borderline PQ type calcium channel antibodiesextreme cortisol concentration may contribute aortic dissection suppress antidiuretic hormone secretion combined hypokalemia due cortisol activation mineralocorticoid receptor manifest diabetes insipidus first report paraneoplastic dysautonomia jejunal intussusception medullary thyroid cancer may related medullary thyroid cancer neuroendocrine origin metastasis respective remission cushings syndrome without measurable reduction cortisol concentration suggest novel cortisol-independent mechanism action assay cross-reactivity normalization dehydroepiandrostenedione sulfate elevation progesterone suggest inhibition 17-hydroxylase 21-hydroxylase activity sorafenib 
24286605 en diabetes insipidus DI characterize hypotonic polyuria great 3 liters24 hour adult persist even water deprivation much due defect arginin-vasopressin AVP synthesis central DI cause AVP resistance nephrogenic DI abnormal thirst regulation primary polydipsia early destruction AVP placental enzyme gestational DI on thorough medical history warrant investigate nocturnal persistence polyuria night waking good sign organic nature specify onset duration trouble medication use potential hereditary nature disorder next step base weight blood pressure measurement especial quantification beverage diuresis 24-hour cycle assessment sign dehydration bladder distention pituitary hormone hyper- hyposecretion tumor chiasmatic syndrome granulomatosis cancer require diagnosis base biological assessment pituitary magnetic resonance imaging MRI result desmopressin test severe form DI urine osmolality remain 250 mosmolkg serum sodium great 145 mmoll partial form DI urine osmolality 250 750 water deprivation test demonstrate incapacity obtain maximal urine concentration valuable together vasopressin copeptin measurement pituitary MRI do investigate lack spontaneous hyperintensity signal posterior pituitary mark absence AVP support diagnosis central DI rather primary polydipsia although absolute also recognize lesion pituitary gland pituitary stalk acquire central DI sudden onset suggest craniopharyngioma germinoma occur age 30 year metastasis age 50 year fifteen 20 head trauma lead hypopituitarism include DI 2 case transient permanent DI present 8-9 endoscopic transphenoidal surgery current advance DI concern etiological work-up particular identification igg4-related hypophysitis many genetic abnormality opening field target therapy year come 
23916565 en datum clinical feature child central diabetes insipidus CDI lack taiwan study investigate clinical manifestation etiology CDI taiwanese childrenfrom 1983 2012 62 child permanent diabetes insipidus enrol study diagnose department pediatrics national taiwan university hospital medical record thorough review clinical symptom sign laboratory datum etiologies analyzedthe patient median age diagnosis 10 year median interval initial manifestation diagnosis 05 year common symptom sign polyuria polydipsia nocturia growth retardation patient low urine osmolality elevated plasma osmolality diagnosis absence posterior pituitary hyperintense signal thickening pituitary stalk common finding magnetic resonance imaging approximate 80 patient anterior pituitary hormone deficiency patient growth hormone deficiency approximate 60 patient intracranial lesion common cause germ cell tumor langerhans cell histiocytosis two patient initial believe idiopathic CDI intracranial lesion detect follow-up periodbecause delay diagnosis CDI common taiwanese child high index suspicion important underlie etiology CDI child may initial obvious long-term surveillance therefore necessary especial early detection evolve treatable intracranial lesion 
24158882 en polydypsia polyuria frequent symptom patient sellar mass cause neurohypophyseal diabetes insipidus autosomal dominant familial neurohypophyseal diabetes insipidus adfndi disorder cause mutation arginine vasopressin AVP -neurophysin ii NPII gene consider rare differential diagnosis on delay diagnosis bear risk life-threatening electrolyte imbalance permanent urinary tract damage leading impair quality lifewe present caucasian kindred little 4 generation fndiclinical history endocrine para-meters result molecular analysis AVP gene present review literature diabetes insipidus DI related urinary tract dilatationpolyuria polydipsia reported base explicit thorough interrogation 4 year clinical follow-up on novel heterozygous mutation AVP gene found examine symptomatic subject c1-33c4del37nt on literature review revealed non-obstructive hydronephrosis NOH rare known complication disince increased fluid intake often typical familial pattern adfndi frequent miss pathologic affected patient therefore detailed clinical history drinking volume critical importance AVP gene testing important component confirmation diagnosis otherwise unexplainable NOH lead investigation evaluation rare disease like FNDI 
3179869 en congenital toxoplasmosis wide range presentation birth varying severe neurological feature hydrocephalus chorioretinitis well appear baby may develop complication late infancy neuroendocrine abnormality associate congenital toxoplasmosis uncommon isolated central diabetes insipidus extreme rarehere report female infant present fever convulsion polyuria examination revealed weight length 3rd centile along sign severe dehydration fundal examination show bilateral chorioretinitis infant develop hypernatremia together increased serum osmolality decrease urine osmolality specific gravity consistent central diabetes insipidus serology toxoplasma specific immunoglobulin M high mother baby polymerase chain reaction toxoplasma deoxyribonucleic acid positive infant confirming congenital toxoplasmosis brain computerize tomography scan demonstrated ventriculomegaly associate cerebral cortical calcification fluid electrolyte abnormality respond nasal vasopressin therapythis report highlight central diabetes inspidus rare presentation congenital toxoplasmosis 
25558016 en nocturnal enuresis common symptom child usual attribute benign cause diagnostic evaluation carry report three male young patient initial present short stature nocturnal enuresis related diabetes insipidus cause intracranial germinomatous germ cell tumors three case water deprivation test confirmed diabetes insipidus extensive endocrinological investigation also show hormone deficiency magnetic resonance imaging brain revealed presence central nervous system lesion histology confirmed final diagnosis surgery radiation without chemotherapy conduct patient treat hormone replacement therapy patient long follow-up free disease present case alert clinician bear mind presence intracranial germinomatous germ cell tumor little consider child present bed wetting especial additional symptom sign include late onset puberty growth delay morning hypernatremia may coexist 
21392661 en diabetes insipidus DI rare disorder horse characterize profound polyuria polydipsia PUPD cause loss production arginine vasopressin AVP condition term neurogenic central DI DI may also develop absence loss AVP receptor activity basolateral membrane collecting-duct epithelial cell condition term nephrogenic DI equine clinician may differentiate true DI common cause PUPD systematic diagnostic approach DI may correctable disorder supportive care affected horse require adequate water source 
22026638 en central diabetes insipidus rare clinical condition heterogenous aetiology 40 case classified idiopathic although many thought autoimmune basis publish datum suggested anterior hypopituitarism common childhood-onset idiopathic diabetes insipidus aim assess incidence anterior hypopituitarism cohort adult patient idiopathic diabetes insipiduswe perform retrospective review database two pituitary investigation unit identify 39 patient idiopathic diabetes insipidus undergo magnetic resonance imaging scanning dynamic pituitary testing either insulin tolerance testing ghrharginine short synacthen testing assess anterior pituitary functionone patient partial growth hormone deficiency anterior pituitary hormonal deficit found thirty-three percent little one autoimmune disease addition central diabetes insipidusour datum suggest anterior hypopituitarism rare adult idiopathic diabetes insipidus routine screening patient anterior hypopituitarism may therefore indicate significant prevalence autoimmune disease cohort support hypothesis idiopathic diabetes insipidus may autoimmune aetiology 
11402519 en langerhans cell histiocytosis rare disorder unknown etiology characterize wide clinical spectrum varied behavior diabetes insipidus relative common feature langerhans cell histiocytosis presence diabetes insipidus mellitus associate histiocytosis adult rare knowledge three previous case reportedwe report clinical presentation pathologic finding clinical progress adult female disseminate langerhans cell histiocytosis hypothalamic infiltration multifocal bone involvement associate diabetes insipidus mellitusthe pathogenesis diabetes mellitus association discuss 
25933447 en diabetes insipidus DI result inadequate output antidiuretic hormone ADH pituitary gland central DI inability kidney tubule respond ADH nephrogenic DI ADH octapeptide produce supraoptic paraventricular nucleus hypothalamus store posterior lobe pituitary gland cardiopulmonary bypass CPB show cause six-fold increased circulate ADH level 12 hour surgery however case ADH release may transient suppress due cardioplegia cardiac standstill CPB leading DI present postoperative course 60-year-old man develop transient DI CPB successful treat apply nasal desmopressin therapy relevant biochemical parameter monitor close patient produce excessive urine open heart surgery 
26152015 en evaluate effect idiopathic orthostatic edema effect thyrotoxicosis weight fluctuation fluid retention presence surgical induce panhypopituitarism diabetes insipidus control hormone replacementdextroamphetamine sulfate use weight gain etiologic factor found methimazole use weight loss occur serum T4 free T4 indicate thyrotoxicosissympathomimetic amine therapy effective control weight gain methimazole control weight losshypopituitarism diabetes insipidus control hormone replacement protect fluid retention idiopathic edema 
25248578 en disorder body fluid among common encounter problem practice clinical medicine large part many different disease state potential disrupt fine balance mechanism control intake output water solute therefore behooves clinician treating patient good understanding pathophysiology differential diagnosis management disorder since body water primary determinant osmolality extracellular fluid ECF disorder body water homeostasis divided hypoosmolar disorder excess body water relative body solute hyperosmolar disorder deficiency body water relative body solute classical hyperosmolar disorder diabetes insipidus DI classical hypoosmolar disorder syndrome inappropriate antidiuretic hormone secretion SIADH chapter first review regulatory mechanism underlie water sodium metabolism two major determinant body fluid homeostasis major disorder water metabolism cause hyperosmolality hypoosmolality DI SIADH discuss detail include pathogenesis differential diagnosis treatment disorder 
24781269 en nephrogenic diabetes insipidus NDI characterize kidney inability concentrate urine cause intense polyuria may lead urinary tract dilation report morphological finding urinary tract ten boy NDI specific address presence change urinary tract dilation treatmentpatients diagnose median age 16 year range 016-633 year treat low osmotic diet hydrochlorothiazide-amiloride indomethacin decrease diuresis median 105 mlkgh 44 mlkgh p 0001 three patient show normal renal ultrasound treatment last control remain seven show urinary tract dilation second group dilation reduce treatment four patient disappear remain three child without dilation dilation disappear diagnose treat early persistent dilation median 166 versus 445 year respective median 104 range 23-203 year follow-up patient show urological complicationsmedical treatment disease improve dilation case prevent potential complication regardless good outcome patient periodic urologic follow-up recommend NDI patient 
12516704 en association diabetes mellitus DM diabetes insipidus DI without congenital defect rare report case type 2 diabetes mellitus NIDDM whose blood sugar control insulin develop central diabetes insipidus 2 year late can successive control synthetic vasopressin 
19763586 en gangliogliomas rare tumors composed admixture glial neuronal component usual occur young patient present therapy-resistant seizure clinical presentation ganglioglioma diabetes insipidus extreme rare one case reported early available literature due rarity ganglioglioma consider differential diagnosis patient diabetes insipidusa 7-year boy present polyuria polydipsia progressive visual loss 18 month investigation revealed diabetes insipidus radiographic study brain show solid cystic mass suprasellar region efface third ventricle intraoperatively diffuse thickening bilateral optic nerve optic chiasma noted diagnosis optic glioma consider on biopsy mass take histopathological examination show feature ganglioglioma patient refer radiotherapy lose follow-updiabetes insipidus present symptom ganglioglioma extreme rare benign tumor keep mind patient central diabetes insipidus suprasellar mass lesion report describe second case literature 
22114999 en central diabetes insipidus occur patient overwhelming central nervous system injury may associate brain death clinical picture child acquire central diabetes insipidus acute brain insult seldom reported retrospective review case date january 2000-february 2008 tertiary pediatric intensive care unit fifty-four patient 28 girl 26 boy aged 3 month 18 year enrol etiologies included severe central nervous system infection 352 hypoxic-ischemic event 315 head injury 185 vascular lesion 148 39 722 patient diabetes insipidus diagnose first 2 day acute central nervous system injury 40 740 develop maximum serum sodium concentration 160 meql 16 sequential cerebral salt wasting syndrome develop initial diabetes insipidus presentation overall mortality 2 month admission 778 result demonstrate patient develop central diabetes insipidus acute central nervous system injury manifest high mortality development central diabetes insipidus within first 2 day maximum plasma sodium 160 meql significant predictor outcome 
23275040 en langerhans cell histiocytosis LCH idiopathic group reactive proliferative disease link aberrant immunity pathological characterize clonal proliferation langerhans cell LCH rare involve thymus report case thymic LCH diabetes insipidus first presentation without evidence myasthenia gravis without evidence involvement skin liver spleen bone lung superficial lymph node present case may important clinical implication screening LCH lesion attention attach rare involved site addition common involved organ follow-up imageological examination important final diagnosis 
20953066 en diabetes insipidus rare disorder pregnant woman predating pregnancy appear first time gestation pregnancy usual affect woman HELLP syndrome acute fatty liver pregnancy result reduce hepatic degradation placental vasopressinase leading increased activity although infiltrative disease found cause diabetes insipidus non-pregnant population study show disorder may manifest first time gestation describe case transient diabetes insipidus two subsequent pregnancy female hemochromatosis first symptom disease appear first time beginning third trimester second pregnancy diagnosis establish basis typical clinical presentation confirmed water deprivation test diabetes insipidus result increased activity vasopressinase cause hemochromatosis-induced liver dysfunction presence confirmed pregnancy liver biopsy identification HFE gene mutation subsequent desferrioxamine treatment result less severe clinical course diabetes insipidus last patient pregnancy pregnancy patient successful treat oral desmopressin resistant degradation placental vasopressinase although unrecognized pituitary disorder may pose serious health problem mother fetus hemochromatosis-induced diabetes insipidus case patient demonstrate effective diagnose treat cannot regard contraindication pregnancy 
25923040 en copeptin stable surrogate marker vasopressin release peptide stoichiometrically secrete neurohypophysis due elevated plasma osmolality nonosmotic stress hypothesize following stress pituitary surgery patient neurohypophyseal damage eventual diabetes insipidus DI will exhibit expected pronounced copeptin elevationthe objective evaluate copeptins accuracy predict DI following pituitary surgerythis prospective multicenter observational cohort studythree swiss canadian referral centers usedconsecutive pituitary surgery patient includedcopeptin measured postoperative daily discharge logistic regression model diagnostic performance measure calculated assess relationship postoperative copeptin level diof 205 patient 50 244 develop postoperative DI post-surgically median 25th-75th percentile copeptin level significant lower patient develop DI vs showing complication 29 19-79 pmoll vs 108 52-304 pmoll p 001 logistic regression analysis revealed strong association postoperative copeptin concentration DI even considering known predispose factor DI adjust odd ratio 95 confidence interval 141 116-173 DI see 2227 patient copeptin 25 pmoll positive predictive value 81 specificity 97 140 copeptin 30 pmoll negative predictive value 95 sensitivity 94 postoperative day 1lack standardize DI diagnostic criterium postoperative blood sample copeptin obtain everyday care vs fixed time pointsin patient undergo pituitary procedure low copeptin level despite surgical stress reflect postoperative DI whereas high level virtual exclude copeptin therefore may become novel tool early goal-directed management postoperative DI 
23380272 en gestational diabetes insipidus uncommon clinical disease whose prevalence approximate two three pregnancy per 100000 may isolated associate preeclampsia report case gestational diabetes insipidus twin pregnancy original isolated two month secondary complicated hellp-syndrome recall specific pathophysiology polyuric-polydipsic syndrome pregnancy summarize various cause final discuss indication case isolated gestational diabetes insipidus treatment ddavp 
24352504 en lithium common cause nephrogenic diabetes insipidus li-ndi hydrochlorothiazide HCTZ combined amiloride mainstay treatment li-ndi paradoxical antidiuretic action HCTZ li-ndi general attribute increased sodium water uptake proximal tubule compensation increased volume loss due HCTZ inhibition na-cl cotransporter NCC alternative action HCTZ suggested investigate whether HCTZ exert ncc-independent effect li-ndi polarize mouse cortical collecting duct mpkccd cell HCTZ treatment attenuate li-induced downregulation aquaporin-2 AQP2 water channel abundance cell amiloride reduce cellular li influx epithelial sodium channel enac HCTZ also reduce li influx lower extent HCTZ increased AQP2 abundance top amiloride affect enac-mediated transcellular voltage mpkccd cell express NCC mrna protein datum indicate mpkccd cell HCTZ attenuate lithium-induced downregulation AQP2 independent NCC enac treatment li-ndi NCC knockout mouse HCTZ revealed significant reduce urine volume unchanged urine osmolality increased cortical AQP2 abundance compare li-treated NCC knockout mouse HCTZ treatment result reduce blood li level creatinine clearance alkalinized urinary ph vitro vivo datum indicate part antidiuretic effect HCTZ li-ndi NCC independent may involve tubuloglomerular feedback response-mediated reduction glomerular filtration rate due proximal tubular carbonic anhydrase inhibition 
26134705 en familial central diabetes insipidus DI usual autosomal dominant disorder cause mutation arginine vasopressin-neurophysin ii AVP-NPII gene lead aberrant preprohormone process gradual destruction avp-secreting cellsto determine clinical molecular characteristic patient familial central DI two different turkish familiesthe diagnosis central DI establish 24-h urine collection water deprivation test desmopressin challenge confirm diagnosis familial central DI entire code region AVP-NPII gene amplify sequence on total eight affected patient three unaffected healthy relative two families studiedgenetic analysis revealed previous reported heterozygous mutation pc98x family on heterozygous novel mutation pg45c family b detect exon 2 AVP-NPII gene compare clinical characteristic two families notice age onset symptom family on range 4 7 year 1 year family b additional pituitary bright spot present affected sibling absent affected parentsfamilial central DI progressive disease age onset symptom differ depend mutation bright spot pituitary MRI might present onset become invisible time genetic testing appropriate counseling given familial case central DI ensure adequate treatment avoid chronic water deprivation might result growth retardation childhood 
25225198 en report case central diabetes insipidus DI associate ketamine infusiona 2-year-old girl long-chain 3-hydroxyacyl-coa dehydrogenase deficiency stable hypertrophic cardiomyopathy admitted pediatric intensive care pneumonia subsequent develop respiratory failure require intubation continuous ketamine infusion use sedation facilitation mechanical ventilation short infusion ketamine patient develop DI respond appropriate vasopressinthe naranjo adverse drug reaction probability scale indicate probable relationship development central DI ketamine likely mechanism involve ketamines antagonist action n-methyl-d-aspartate receptor resulting inhibition glutamate-stimulated arginine vasopressin release neurohypophysisthis second case report ketamine-induced central DI report child clinician sedate child continuous ketamine infusion monitor patient develop sign symptom DI measuring serum sodium urine output prior ketamine infusion order make timely diagnosis potential serious complication 
25271879 en central diabetes insipidus CDI rare cause hypernatremia neonatal period diagnosis particular difficult low birth weight VLBW newbornswe report preterm newborn present CDI soon birth third day life sign dehydration present despite normal fluid supply diuresis rate 44 mlkgh although fluid supply increased dehydration continued hypernatremia normal glycemia diuresis 74 mlkgh urine density 1005 mosmoll thus diagnostic hypothesis diabetes insipidus raise on test nasal vasopressin analogue ddavp perform CDI confirmed reduction fluid supply become possible appropriate treatmentthe diagnosis CDI rare make neonatal period especial VLBW newborn difficulty detect elevated diuresis persistent hypernatremia usual accompany hyperthermia despite abundant fluid supply weight loss low urine osmolality important sign alert 
26586714 en central diabetes insipidus CDI cause deficiency antidiuretic hormone characterize polyuria polydipsia inability concentrate urine objective present result molecular analysis avp-neurophysin ii AVP-NPII gene large familial neurohypophyseal central DI pedigree on male patient family member analyzed prospective clinical datum collected proband apply hospital eligibility recruit arm force patient severe polyuria 20 lday polydipsia 205 lday fatique deep thirstiness CDI confirmed water deprivation-desmopressin test according increase urine osmolality 162 mosmkg 432 mosmkg desmopressin acetate injection evaluate code region AVP-NPII gene polymerase chain reaction perform amplify region submit direct sequence analysis detect heterozygous three base pair deletion codon 69-70 207209delggc exon 2 lead deletion amino acid alanine on three-dimensional protein structure prediction show delete AVP-NPII compare wild type three base pair deletion may yield abnormal AVP precursor neurophysin moiety functional analysis need understand function delete protein 
19454377 en review approach patient diabetes insipidus pregnancythis review examine normal physiology water homeostasis related change occur pregnancy pathophysiology diabetes insipidus pregnancy associate complication evaluation management discusseddiabetes insipidus complicate 1 30000 pregnancy diabetes insipidus pregnancy variety cause predate pregnancy other begin gestation polyuria polydipsia occur exacerbate woman overt subclinical central nephrogenic diabetes insipidus woman either decrease central secretory reserve impair renal responsive vasopressin addition woman experience diabetes insipidus de novo pregnancy action placental vasopressinase cause accelerated degradation vasopressin form diabetes insipidus may associate increased complication pregnancy include preeclampsia management central diabetes insipidus transient diabetes insipidus pregnancy achieve 1-deamino-8-d-arginine vasopressin desmopressin acetate DDAVP vasopressin analogue nephrogenic diabetes insipidus typical resistant DDAVP vasopressin underlie cause addressedincreased aware diabetes insipidus pregnancy may lead early diagnosis appropriate treatment reduce risk maternal fetal morbidity overall growing experience DDAVP show safe effective treatment diabetes insipidus cause variety factor 
24588923 en review incidence spectrum clinical manifestation course risk factor well treatment diabetes insipidus DI following neurosurgery pituitary glandthe file 24 patient undergo neurosurgery sellar lesion tumor near hypothalamus pituitary gland department neurosurgery king abdulaziz university hospital jeddah kingdom saudi arabia retrospective review january 2011 december 2014 on total 24 patient studied divided 2 group namely DI non-di patient characteristic studied use descriptive statistic difference proportion 2 group found use z-test proportion 2 population mean difference hormonal abnormality 2 group assess use independent t-test statistic consider statistical significant p less 005during hospitalization 13 542 24 patient undergo neurosurgery manifestation DI transient 5 388 permanent 8 612 DI subgroup contained high prevalence prolactinoma craniopharyngioma pre-operative panhypopituitarism macroadenoma MRI imaging transphenoidal surgery furthermore urine osmolality significant lower DI group post-operatively significant p0023 recognize permanent DI document significant numbers studiesin study group recognize permanent DI mean patient need desmopressin 3 month document significant number study 
26504422 en lithium-associated hyperparathyroidism leading cause hypercalcemia lithium-treated patient lithium may lead exacerbation pre-existing primary hyperparathyroidism cause increased set-point calcium parathyroid hormone suppression leading parathyroid hyperplasia lithium may cause renal tubular concentration defect direct development nephrogenic diabetes insipidus indirect effect hypercalcemia study present female patient long-term lithium treatment evaluate hypercalcemia preoperative imaging study indicate parathyroid adenoma multinodular goiter parathyroidectomy thyroidectomy plan postoperative course prolong intubation necessary agitation delirium period polyuria severe dehydration hypernatremia develop respond control hypotonic fluid infusion unresponsive parenteral desmopressin on diagnosis nephrogenic diabetes insipidus apparent on parathyroid adenoma multifocal papillary thyroid cancer detect histopathological examination thought nephrogenic diabetes insipidus mask hypercalcemia preoperatively on patient lithium treatment careful follow surgery prevent life-threatening complication previous unrecognized nephrogenic diabetes insipidus possibility renal concentrate defect long-term lithium use seek particular patient impair conscious 
25439412 en on case intraoperative administration propofol strong associate acute episode diabetes insipidus present 
23977893 en diabetes insipidus DI rare disease human animal cause lack production malfunction dysfunction distal nephron antidiuretic effect antidiuretic hormone ADH diagnosis require thorough medical history clinical examination laboratory confirmation case report describe appearance DI five duroc boar switzerlandtwo purebred intact duroc boar age 8 month 15 year respective history polyuric polydipsic symptom refer swine clinic berne base case history result clinical examination analysis blood urine tentative diagnosis DI conclude final diagnosis confirmed finding modify water deprivation test macroscopic examination histopathology following diagnosis three genes known involved inherit DI human analyzed order explore possible genetic background affected boarsthe etiology DI pig supposed human although disease never describe pig thus although occur rare occasion DI consider differential diagnosis pig polyuria polydipsia seem modify water deprivation test may helpful tool confirming diagnosis pig since hereditary form DI describe human occurrence DI pig consider breeding program although able identify disease associate mutation 
26353165 en diabetes insipidus DI one common disorder affecting sodium water homeostasis result ADH either inadequate produce unable negotiate action renal collecting tubule aquaporins diagnostic algorithm start exclusion cause polyuria establish low urine osmolality presence high serum osmolality paper review diagnosis etiology management DI child special emphasis recent advance field 
23666224 en on 20-year-old female present thirst polyposia polyuria refer hospital leukocytosis anemia bone marrow aspiration revealed 668 myeloperoxidase-positive blast trilineage myelodysplasia karyotype 45 XX inv3q21q262 -719 therefore diagnosis AML inv3q21q262 complicated -7 make moreover hyposthenuria low anti-diuretic hormone ADH level observed although cerebrospinal fluid analysis normal magnetic resonance imaging MRI revealed absence hyperintensity neurohypophysis t1-weighted image therefore also diagnose diabetes insipidus administer desmopressin nasal spray volume urine produce decrease following treatment second induction therapy contain high-dose cytarabine AML achieve complete remission bone marrow moreover abnormality MRI volume urine normalize discontinue desmopressin although diabetes insipidus rare complication AML majority AML patient diabetes insipidus abnormal karyotypes inv3q21q262t33q21q262 monosomy 7 study require clarify pathogenesis develop strategy treatment category AML 
23563855 en purpose prospective study assess physiologic change renal corticomedullary 23na-concentration 23na gradient 23na-mri 30T patient central diabetes insipidus CDI intranasal administration 20 g desmopressin ddavpfour patient CDI male mean age 602 year included irb-approved study 23na-imaging 3D density adapted radial gre-sequence Te 055 ms TR 120 ms projection 8000 spatial resolution 5 5 5 mm3 use combination dedicate 23na-coil reference phantom corticomedullary 23na gradient mmollmm calculated pixel-by-pixel along linear region-of-interest ROI span renal cortex direction medulla mean sds 23na calculated patient well entire groupmean 23na increased along corticomedullary gradient cortex pre-ddavp 380 63 mmoll vs post-ddavp 307 35 mmoll medulla pre-ddavp 716 148 mmoll vs post-ddavp 597 108 mmoll overall mean decrease 23na DDAVP administration 171 11 23na-mri state-of-the-art technique 3T depict physiologic renal response administration desmopressin patient central diabetes insipidus 
25430399 en patient cranial diabetes insipidus CDI risk develop hypernatraemia hyponatraemia due condition secondary treatment vasopressin-analogues administration iv fluid aim assess frequency impact dysnatraemias inpatient INPT outpatient opt setting desmopressin-treated CDI compare normal thirst abnormal thirstthe study included 192 patient cranial diabetes identify beaumont pituitary database tertiary referral centre retrospective case note audit perform clinical biochemical information 147 patient CDI available analysisa total 4142 plasma sodium measurement 137 patient normal thirst 385 plasma sodium measurement ten patient abnormal thirst analyse normal thirst common opt abnormality mild hyponatraemia pna 131-134 mmoll 27 146 significant hyponatraemia pna 130 mmoll patient normal thirst 58 admitted due complication direct related hyponatraemia compare patient normal thirst abnormal thirst likely develop significant opt hypernatraemia 20 vs 14 P002 significant INPT hyponatraemia 50 vs 111 p 002OPT management CDI complicated significant incidence hyponatraemia contrast opt hypernatraemia almost exclusive complication see adipsic CDI also frequent INPT hyponatraemia CDI associate thirst disorder require increased physician attention patient aware potential complication 
23242859 en diabetes insipidus DI endoscopic transsphenoidal surgery ETSS lead increased morbidity longer hospital stay increased medication requirement predict patient high risk develop DI help direct service ensure adequate care follow-up objective study review institution experience ETSS determine clinicallaboratory variable associate DI patient population author want see easy determined single value will help predict patient develop DI represent large north american series type retrospective review chart patient undergo ETSS resection sellar parasellar pathology 2006 2011 examine patient tumor characteristic relationship postoperative DI 172 endoscopic transsphenoidal surgery 15 case transient DI 87 14 case permanent DI 81 statistical significant predictor postoperative DI p 005 included tumor volume histopathology rathkes cleave cyst craniopharyngioma significant indicator development DI postoperative serum sodium preoperative postoperative change sodium level urine output prior administration 1-deamino-8-d-arginine vasopressin increase serum sodium 25 mmoll positive marker development DI 80 specificity postoperative serum sodium 145 mmoll positive indicator 98 specificity identify perioperative risk factor objective indicator DI ETSS help physician care patient postoperative large series demonstrated multiple perioperative risk factor development DI finding consistent report microscopic surgical series help identify patient risk diabetes insipidus aid planning treatment algorithm increase vigilance high risk patient 
